Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,421,401
+$1,414,508 QoQ
Shares Held
37,440
+1.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#951
of 4,145 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Western Wealth Management, LLC holds $46,869,969 across 12 Drug Manufacturers - General names. ABBV ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,981 | $15,569,801 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
37,440 | $9,421,401 | |
| 3 | JNJ |
Johnson & Johnson
|
32,063 | $8,143,039 | |
| 4 | MRK |
Merck & Co., Inc.
|
31,663 | $4,068,695 | |
| 5 | AMGN |
Amgen Inc
|
10,288 | $3,725,490 | |
| 6 | PFE |
Pfizer Inc
|
82,496 | $1,986,502 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
21,798 | $1,256,000 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,933 | $1,002,254 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,421,401 | 37,440 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,006,893 | 36,815 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $5,441,260 | 23,814 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,054,286 | 21,829 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,036,121 | 21,744 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,503,003 | 21,492 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,794,783 | 21,355 | Shares | Sole | 2025-04-16 | |
| 2024-09-30 | $7,128,238 | 36,096 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,567,101 | 20,797 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $3,688,981 | 20,258 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $5,473,385 | 35,319 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $5,563,068 | 37,321 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,883,423 | 36,246 | Shares | Sole | 2023-08-30 | |
| 2023-03-31 | $6,048,410 | 37,952 | Shares | Sole | 2023-08-30 | |
| 2022-12-31 | $5,404,723 | 33,443 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $7,416,981 | 55,264 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $8,501,911 | 55,510 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $9,180,937 | 56,634 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,119,209 | 23,037 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $3,285,934 | 29,172 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,938,977 | 17,917 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,847,801 | 17,245 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,541,934 | 17,604 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,602,199 | 16,319 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $898,280 | 11,790 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||